Study reveals a reprogrammed role for the androgen receptor
Monday, July 27, 2009 - 12:35
in Health & Medicine
BOSTON -- The androgen receptor -- a protein ignition switch for prostate cancer cell growth and division -- is a master of adaptability. When drug therapy deprives the receptor of androgen hormones, thereby halting cell proliferation, the receptor manages to find an alternate growth route.